|
Market Cap (24-Jun) $7,328,050 (1,632nd) |
Close (30-Jun) $0.010 |
Volume (30-Jun) 290,000 |
Shortsold (24-Jun) - |
|
52w High $0.029 |
52w Low $0.015 |
P/E - |
EPS -0.01 |
NGS released this announcement to the ASX on 6 September 2021, 17:55. The announcement is not marked as price sensitive, and is 6 page(s) in length and 25.12kb in size.
You can view all announcements from NGS and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from NGS | |
|---|---|
| Notice of Annual General Meeting/Proxy Form | 20 June 2023, 18:13 |
| Update on North American Expansion Strategy | 31 May 2023, 8:57 |
| Investor Webinar | 30 May 2023, 12:26 |
| Application for quotation of securities - NGS | 6 September 2021, 17:55 |
| Positive Clinical Trial Results for Boys 10 and over | 2 September 2021, 8:58 |
| Proposed issue of securities - NGS | 30 August 2021, 9:42 |
| NGS finalises $5m capital raise for continued growth | 30 August 2021, 9:41 |
You must be logged in to post a reply.
